Safety and Efficacy of Endoscopic Dilation for Primary Crohn’s Disease Strictures in the Upper GI Tract

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

     

    Amandeep Singh, MD

    Amandeep Singh, MD

    Poster 1051 Safety and Efficacy of Endoscopic Dilation for Primary Crohn’s Disease Strictures in the Upper GI Tract

    Author Insight from Amandeep Singh, MD, Cleveland Clinic Foundation

     

    What’s new here and important for clinicians?

    Our preliminary data indicates that endoscopic balloon dilations of primary Crohn’s strictures of the upper gastrointestinal tract is a safe and effective treatment modality (technical success 94%, clinical efficacy 88%), with a low complication rate (4%). It leads to prolonged clinical benefit with need for redilation in 62.9% and surgery in 26.8% during a median follow-up of 23 months. It should be considered as an alternative to surgery in all CD-related primary UGI strictures amenable to endoscopic intervention.

    What do patients need to know?

    Endoscopic balloon dilatation is a non-surgical option for Crohn’s disease-induced upper gastrointestinal strictures. It is very safe and effective. It can be done multiple times without any additional complications at subsequent dilations.

    Read the abstract

    Author Contact

    Amandeep Singh, MD, Cleveland Clinic Foundation

    bansraoaman@yahoo.com

     


    Media Interview Requests:

    To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks